Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $330.25 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Theravance Biopharma Inc. | $142.85 | 1 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $115.60 | 2 | $0 (2018) |
| Melinta Therapeutics, Inc. | $26.98 | 2 | $0 (2019) |
| Allergan Inc. | $18.75 | 1 | $0 (2018) |
| Insmed, Inc. | $14.37 | 1 | $0 (2020) |
| Smith & Nephew, Inc. | $11.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $14.37 | 1 | Insmed, Inc. ($14.37) |
| 2019 | $11.98 | 1 | Melinta Therapeutics, Inc. ($11.98) |
| 2018 | $47.62 | 3 | Allergan Inc. ($18.75) |
| 2017 | $256.28 | 3 | Theravance Biopharma Inc. ($142.85) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/17/2020 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: Respiratory | ||||||
| 08/09/2019 | Melinta Therapeutics, Inc. | Orbactiv (Drug), Vabomere | Food and Beverage | In-kind items and services | $11.98 | General |
| Category: ANTIBIOTICS | ||||||
| 12/12/2018 | Allergan Inc. | TEFLARO (Drug) | Food and Beverage | In-kind items and services | $18.75 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/01/2018 | Melinta Therapeutics, Inc. | Baxdela (Drug), Vabomere, Orbactiv | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 03/27/2018 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $13.87 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 09/26/2017 | Merck Sharp & Dohme Corporation | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $101.73 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 07/06/2017 | Theravance Biopharma Inc. | — | Food and Beverage | In-kind items and services | $142.85 | General |
| 02/09/2017 | Smith & Nephew, Inc. | PICO (Device) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: Negative Pressure Wound Therapy | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 20 | $2,600 | $846.40 |
| 2022 | 1 | 23 | 30 | $6,990 | $1,846 |
| 2021 | 3 | 57 | 83 | $23,779 | $6,381 |
| 2020 | 2 | 42 | 45 | $9,570 | $3,681 |
All Medicare Procedures & Services
7 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 16 | 20 | $2,600 | $846.40 | 32.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 23 | 30 | $6,990 | $1,846 | 26.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 31 | 53 | $12,349 | $3,369 | 27.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 14 | 18 | $6,030 | $1,614 | 26.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 12 | 12 | $5,400 | $1,398 | 25.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 16 | 16 | $4,656 | $1,884 | 40.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 26 | 29 | $4,914 | $1,797 | 36.6% |
About Dr. Kevin Ng, M.D
Dr. Kevin Ng, M.D is a Infectious Disease healthcare provider based in Camden, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1174936736.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevin Ng, M.D has received a total of $330.25 in payments from pharmaceutical and medical device companies, with $14.37 received in 2020. These payments were reported across 8 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($330.25).
As a Medicare-enrolled provider, Ng has provided services to 138 Medicare beneficiaries, totaling 178 services with total Medicare billing of $12,754. Data is available for 4 years (2020–2023), covering 7 distinct procedure/service records.
Practice Information
- Specialty Infectious Disease
- Location Camden, NJ
- Active Since 06/11/2014
- Last Updated 01/28/2020
- Taxonomy Code 207RI0200X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1174936736
Products in Payments
- ZERBAXA (Drug) $115.60
- TEFLARO (Drug) $18.75
- Baxdela (Drug) $15.00
- Arikayce (Drug) $14.37
- Orbactiv (Drug) $11.98
- PICO (Device) $11.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Camden
Dr. Akinwale Olatosi, M.b.b.s, M.B.B.S
Infectious Disease — Payments: $41,876
Dr. Pola Dela Torre, Md, MD
Infectious Disease — Payments: $16,627
Dana Byrne, Md, MD
Infectious Disease — Payments: $1,885
Henry Fraimow, Md, MD
Infectious Disease — Payments: $1,513
Danielle Zambrano, Do, DO
Infectious Disease — Payments: $671.74
Lisa Pedroza, Md, MD
Infectious Disease — Payments: $650.52